HER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidate

  • Catalog number
    HER2-613-P
  • Price
    Please ask
  • Size
    5 mg
  • Stock availability
    Available
  • Category
    Antibody Blocking Peptide
  • Antibody type
    N/A
  • Antibody host
    N/A
  • Antibody conjugate
    N/A
  • Technical datasheet
    Contact Gentaur to request the datasheet or ask our specialists for more information.
  • Notes
    The HER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidate is manufactured for Research Use Only or for diagnostics purposes.
  • Description
    Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
  • Gene target
  • Gene symbol
    MIR626, MIR613, ERBB2
  • Short name
    HER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidate
  • Technique
    peptide, peptides
  • Species
    Human
  • Alternative name
    HER2 short protein sequence, cyclic, (613-626, cys-cys disulphide bond); immunization candidate
  • Alternative technique
    peptides
Gene info
Gene info
Gene info
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee